Roots
Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market, 2021-2030.” 

The
report features an extensive study of the current market landscape and future
opportunities associated with cell therapy manufacturing. It focuses on both
contract manufacturers, as well as developers with in-house manufacturing
facilities, offering in-depth analyses of the various business entities that
are engaged in this domain, across different global regions. Amongst other
elements, the report includes:

·       
An analysis of the various expansion
initiatives undertaken by service providers, in order to augment their
respective cell therapy manufacturing capabilities, over the period 2015-2019.

·       
An analysis of the recent partnerships
focused on the manufacturing of cell-based therapies, which have been
established in the period 2014-2019.

·       
Informed estimates of the annual commercial
and clinical demand for cell therapies, in terms of number of cells produced
and area dedicated to manufacturing.

·       
An estimate of the overall, installed capacity
for manufacturing cell-based therapies based on information reported by
industry stakeholders in the public domain A competitiveness analysis of
biological targets, featuring insightful pictorial summaries and
representations.

·       
A detailed analysis of the various factors
that are likely to influence the pricing of cell-based therapies, featuring
different models / approaches that may be adopted by manufacturers while
deciding the prices of their proprietary offerings.

·       
A qualitative analysis, highlighting the
various factors that need to be taken into consideration by cell therapy
developers while deciding whether to manufacture their respective products
in-house or engage the services of a CMO.

·       
An elaborate discussion on the role of
automation technologies in improving current manufacturing methods.

·       
A discussion on cell therapy manufacturing
regulations across various geographies, including North America, Europe, and
Asia Pacific.

·       
Elaborate profiles of key players (industry
and non-industry) that offer contract manufacturing services.

·       
A discussion on affiliated trends, key
drivers and challenges, which are likely to impact the industry’s evolution,
under a comprehensive SWOT framework.

Get Detailed
Market Analysis:

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html